Jumonji represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2 activity

Tae-gyun Kim1, Jooyoung Jung, Matthew R Mysliwiec

  • 1Department of Anatomy and Cardiovascular Research Center, University of Wisconsin Medical School, Madison, WI 53706, USA.

Insights

Jumonji (JMJ) represses alpha-cardiac myosin heavy chain (alphaMHC) gene expression by inhibiting myocyte enhancer factor 2 (MEF2) activity. This protein-protein interaction is crucial for regulating cardiac gene expression during development and disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Gene Regulation

Background:

  • Alpha-cardiac myosin heavy chain (alphaMHC) gene expression is vital for heart development and function, decreasing in cardiac myopathy.
  • Jumonji (JMJ) is essential for cardiovascular development and acts as a transcriptional repressor.

Purpose of the Study:

  • To investigate the mechanism by which JMJ regulates alphaMHC expression.
  • To determine the role of JMJ in repressing myocyte enhancer factor 2 (MEF2) activity.

Main Methods:

  • Overexpression of JMJ in primary cardiomyocytes.
  • Analysis of alphaMHC gene expression.
  • Investigation of protein-protein interactions between JMJ and MEF2 isoforms.

Main Results:

  • JMJ overexpression significantly reduced endogenous alphaMHC expression.
  • JMJ repressed the synergistic activation of alphaMHC by MEF2 and thyroid hormone receptor (TR).
  • JMJ directly interacted with MEF2A, inhibiting its transcriptional activity.

Conclusions:

  • JMJ represses alphaMHC expression through direct physical interaction with MEF2A.
  • This interaction mechanism is critical for regulating cardiac gene expression and may be relevant in cardiac disease states.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...